CoreCap Advisors’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$299K Buy
619
+596
+2,591% +$158K 0.01% 710
2026
Q1
$2.52K Sell
23
-1,311
-98% -$187K ﹤0.01% 2353
2025
Q4
$222K Buy
1,334
+605
+83% +$101K 0.01% 759
2025
Q3
$143K Sell
729
-560
-43% -$92.1K 0.01% 905
2025
Q2
$117K Buy
1,289
+1,271
+7,061% +$100K ﹤0.01% 933
2025
Q1
$1.07K Sell
18
-95
-84% -$8.79K ﹤0.01% 2513
2024
Q4
$15K Buy
+113
New +$10.6K ﹤0.01% 1628

Other funds holding ALAB

CoreCap Advisors's ALAB Position: Q2 2026 in Review

CoreCap Advisors increased its Astera Labs (ALAB) stake by 2,591% in Q2 2026, buying an estimated $158K and bringing the position to 619 shares worth $299K. The position accounts for 0.01% of the portfolio, ranked #710.

CoreCap Advisors first reported a position in ALAB in Q4 2024 and has held it in 7 quarters since. 107 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • CoreCap Advisors held 619 shares of Astera Labs worth $299K as of Q2 2026.
  • CoreCap Advisors bought 596 Astera Labs shares in Q2 2026, an estimated $158K.
  • Astera Labs made up 0.01% of CoreCap Advisors's portfolio in Q2 2026, its #710 holding.
  • CoreCap Advisors first reported a position in Astera Labs in Q4 2024 and has held it in 7 quarters since.
  • 107 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on CoreCap Advisors's 13F filing for Q2 2026, filed 6 Jul 2026.